RSS-Feed abonnieren
DOI: 10.1055/s-0035-1569358
Melatonin as Protection Against Radiation Injury: A Systematic Review
Publikationsverlauf
received 12. Oktober 2015
accepted 10. Dezember 2015
Publikationsdatum:
20. Januar 2016 (online)
![](https://www.thieme-connect.de/media/drugres/201606/lookinside/thumbnails/2015-10-1089_10-1055-s-0035-1569358-1.jpg)
Abstract
Introduction: Radiation is widely used in the treatment of various cancers and in radiological imaging procedures. Ionizing radiation causes adverse effects, leading to decreased quality of life in patients, by releasing free radicals that cause oxidative stress and tissue damage. The sleep-hormone melatonin is a free radical scavenger, and induces several anti-oxidative enzymes. This review investigates the scientific literature on the protective effects of melatonin against exposure to ionizing radiation, and discusses the clinical potential of melatonin as prophylactic treatment against ionizing radiation damage.
Methods: A systematic literature search was performed and included experimental or clinical studies written in English that investigated the protective effects of melatonin against gamma or X-ray irradiation in vivo. Studies were excluded if patients were treated with chemotherapy concomitantly.
Results: 37 studies were included in the review. All were of experimental case-control design and employed animals. The studies demonstrated that exogenous melatonin reduced oxidative stress and inflammation in all investigated tissues. Furthermore, melatonin increased 30-day survival and protected against radiation enteritis. These protective effects were only documented when melatonin was administered prior to exposure to ionizing radiation.
Discussion: This review documents that melatonin effectively protects animals against injury to healthy tissues from ionizing radiation. However, no studies have been performed in humans. If clinical studies can document similar protective effects, melatonin could have a great potential to prevent side effects of radiotherapy for cancer, to protect against increased long-term cancer risk in radiological imaging procedures, and to protect from radiation due to nuclear incidents.
Supporting Information
- for this article is available online at http://www.thieme-connect.de/products
- Supporting Information
-
References
- 1 Rodrigues G, Choy H, Bradley J et al. Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Pract Radiat Oncol 2015; 5: 141-148
- 2 Klopp A, Smith BD, Alektiar K et al. The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2014; 4: 137-144
- 3 Minicozzi P, Bouvier AM, Faivre J et al. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients. Dig Liver Dis 2014; 46: 645-651
- 4 Valicenti RK, Thompson Jr I, Albertsen P et al. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys 2013; 86: 822-828
- 5 Smith BD, Bentzen SM, Correa CR et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 81: 59-68
- 6 Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 2007; 8: 1007-1017
- 7 Donovan KA, Taliaferro LA, Alvarez EM et al. Sexual health in women treated for cervical cancer: characteristics and correlates. Gynecol Oncol 2007; 104: 428-434
- 8 Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994; 74: 2520-2532
- 9 Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004; 363: 345-351
- 10 Smith-Bindman R, Lipson J, Marcus R et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169: 2078-2086
- 11 Reiter RJ, Tan DX, Korkmaz A et al. The disaster in Japan: utility of melatonin in providing protection against ionizing radiation. J Pineal Res 2011; 50: 357-358
- 12 Scholes G. Radiation effects on DNA. The Silvanus Thompson Memorial Lecture, April 1982. Br J Radiol 1983; 56: 221-231
- 13 Nair CK, Parida DK, Nomura T. Radioprotectors in radiotherapy. J Radiat Res 2001; 42: 21-37
- 14 Tan DX, Manchester LC, Reiter RJ et al. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 2000; 9: 137-159
- 15 Reiter RJ, Guerrero JM, Garcia JJ et al. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci 1998; 854: 410-424
- 16 Costa EJ, Shida CS, Biaggi MH et al. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett 1997; 416: 103-106
- 17 Shida CS, Castrucci AM, Lamy-Freund MT. High melatonin solubility in aqueous medium. J Pineal Res 1994; 16: 198-201
- 18 Menendez-Pelaez A, Poeggeler B, Reiter RJ et al. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53: 373-382
- 19 Manchester LC, Coto-Montes A, Boga JA et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 2015; 59: 403-419
- 20 Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-341
- 21 Moher D, Shamseer L, Clarke M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015 4. 1
- 22 Koc M, Buyukokuroglu ME, Taysi S. The effect of melatonin on peripheral blood cells during total body irradiation in rats. Biol Pharm Bull 2002; 25: 656-657
- 23 Guney Y, Hicsonmez A, Uluoglu C et al. Melatonin prevents inflammation and oxidative stress caused by abdominopelvic and total body irradiation of rat small intestine. Braz J Med Biol Res 2007; 40: 1305-1314
- 24 Koc M, Taysi S, Emin Buyukokuroglu M et al. The effect of melatonin against oxidative damage during total-body irradiation in rats. Radiat Res 2003; 160: 251-255
- 25 Shirazi A, Mihandoost E, Ghobadi G et al. Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage. Cell J 2013; 14: 292-297
- 26 Shirazi A, Haddadi GH, Asadi-Amoli F et al. Radioprotective effect of melatonin in reducing oxidative stress in rat lenses. Cell J 2011; 13: 79-82
- 27 Take G, Erdogan D, Helvacioglu F et al. Effect of melatonin and time of administration on irradiation-induced damage to rat testes. Braz J Med Biol Res 2009; 42: 621-628
- 28 Bhatia AL, Manda K. Study on pre-treatment of melatonin against radiation-induced oxidative stress in mice. Environ Toxicol Pharmacol 2004; 18: 13-20
- 29 Kundurovic Z, Scepovic M. Histoenzymological reactions of the thyroid gland in irradiated and previously melatonin-treated irradiated rats. Acta Med Iugosl 1989; 43: 337-347
- 30 Vijayalaxmi Meltz ML, Reiter RJ. et al. Melatonin and protection from whole-body irradiation: survival studies in mice. Mutat Res 1999; 425: 21-27
- 31 Taysi S, Koc M, Buyukokuroglu ME et al. Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver. J Pineal Res 2003; 34: 173-177
- 32 Orbak Z, Ertekin V, Yildirim M et al. Effect of Melatonin on Bone Mineral Density of Irradiated Rats. Yakhteh 2011; 12: 459-462
- 33 Yavuz MN, Yavuz AA, Ulku C et al. Protective effect of melatonin against fractionated irradiation-induced epiphyseal injury in a weanling rat model. J Pineal Res 2003; 35: 288-294
- 34 Haddadi G, Shirazi A, Sepehrizadeh Z et al. Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats. Cell J 2013; 14: 246-253
- 35 Karslioglu I, Ertekin MV, Taysi S et al. Radioprotective effects of melatonin on radiation-induced cataract. J Radiat Res 2005; 46: 277-282
- 36 Shirazi A, Haddadi GH, Ghazi-Khansari M et al. Evaluation of Melatonin for Prevention of Radiation Myelopathy in Irradiated Cervical Spinal Cord. Yakhteh 2009; 11: 43-48
- 37 Erol FS, Topsakal C, Ozveren MF et al. Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study. Neurosurg Rev 2004; 27: 65-69
- 38 Sener G, Atasoy BM, Ersoy Y et al. Melatonin protects against ionizing radiation-induced oxidative damage in corpus cavernosum and urinary bladder in rats. J Pineal Res 2004; 37: 241-246
- 39 Yildirim O, Comoglu S, Yardimci S et al. Preserving effects of melatonin on the levels of glutathione and malondialdehyde in rats exposed to irradiation. Gen Physiol Biophys 2008; 27: 32-37
- 40 Badr FM, El Habit OH, Harraz MM. Radioprotective effect of melatonin assessed by measuring chromosomal damage in mitotic and meiotic cells. Mutat Res 1999; 444: 367-372
- 41 Gurses I, Ozeren M, Serin M et al. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract 2014; 210: 863-871
- 42 Kundurovic Z, Sofic E. The effects of exogenous melatonin on the morphology of thyrocytes in pinealectomized and irradiated rats. J Neural Transm 2006; 113: 49-58
- 43 Alicelebic S, Mornjakovic Z, Susko I et al. The role of pineal gland and exogenous melatonin on the irradiation stress response of suprarenal gland. Bosn J Basic Med Sci 2006; 6: 18-21
- 44 El-Missiry MA, Fayed TA, El-Sawy MR et al. Ameliorative effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury. Ecotoxicol Environ Saf 2007; 66: 278-286
- 45 Assayed ME, Abd El-Aty AM. Protection of rat chromosomes by melatonin against gamma radiation-induced damage. Mutat Res 2009; 677: 14-20
- 46 Sharma S, Haldar C, Chaube SK et al. Long-term melatonin administration attenuates low-LET gamma-radiation-induced lymphatic tissue injury during the reproductively active and inactive phases of Indian palm squirrels (Funambulus pennanti). Br J Radiol 2010; 83: 137-151
- 47 Monobe M, Hino M, Sumi M et al. Protective effects of melatonin on gamma-ray induced intestinal damage. Int J Radiat Biol 2005; 81: 855-860
- 48 Haridas S, Kumar M, Manda K. Chronic melatonin administration mitigates behavioral dysfunction induced by gamma-irradiation. Horm Behav 2012; 62: 621-627
- 49 Sisodia R, Kumari S, Verma RK et al. Prophylactic role of melatonin against radiation induced damage in mouse cerebellum with special reference to Purkinje cells. J Radiol Prot 2006; 26: 227-234
- 50 Vasin MV, Ushakov IB, Kovtun VY et al. Therapeutic effect of long-term melatonin treatment on the course and fatal outcome of modeled acute radiation sickness. Bull Exp Biol Med 2014; 156: 776-777
- 51 Ozmerdivenli R, Karacabey K, Gundogdu C et al. Protective role of melatonin on blood parameters following irradiation in rat. African Journal of Biotechnology 2011; 10: 18564-18568
- 52 Hussein MR, Abu-Dief EE, Abou El-Ghait AT et al. Melatonin and roentgen irradiation of the testis. Fertil Steril 2006; 86: 750-752
- 53 Hussein MR, Abu-Dief EE, Kamel E et al. Melatonin and roentgen irradiation-induced acute radiation enteritis in Albino rats: an animal model. Cell Biol Int 2008; 32: 1353-1361
- 54 Hussein MR, Abu-Dief EE, Abou El-Ghait AT et al. Morphological evaluation of the radioprotective effects of melatonin against X-ray-induced early and acute testis damage in Albino rats: an animal model. Int J Exp Pathol 2006; 87: 237-250
- 55 Sener G, Jahovic N, Tosun O et al. Melatonin ameliorates ionizing radiation-induced oxidative organ damage in rats. Life Sci 2003; 74: 563-572
- 56 Sharma S, Haldar C, Chaube SK. Effect of exogenous melatonin on X-ray induced cellular toxicity in lymphatic tissue of Indian tropical male squirrel, Funambulus pennanti. Int J Radiat Biol 2008; 84: 363-374
- 57 Sharma S, Haldar C. Melatonin prevents X-ray irradiation induced oxidative damage in peripheral blood and spleen of the seasonally breeding rodent, Funambulus pennanti during reproductively active phase. Int J Radiat Biol 2006; 82: 411-419
- 58 Topkan E, Tufan H, Yavuz AA et al. Comparison of the protective effects of melatonin and amifostine on radiation-induced epiphyseal injury. Int J Radiat Biol 2008; 84: 796-802
- 59 Hazewinkel MH, Sprangers MA, van der Velden J et al. Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study. Gynecol Oncol 2010; 117: 281-286
- 60 Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 2002; 52: 1207-1219
- 61 Shimizu Y, Kato H, Schull WJ et al. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950–1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res 1992; 130: 249-266
- 62 Gogenur I, Kucukakin B, Panduro Jensen L et al. Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo-controlled, clinical trial. J Pineal Res 2014; 57: 10-15
- 63 Gitto E, Romeo C, Reiter RJ et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004; 39: 184-189 discussion -9
- 64 Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2002; 2: 113-132
- 65 Mills E, Wu P, Seely D et al. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 2005; 39: 360-366
- 66 Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005; 27: 179-188